1. Avian influenza reaches European dairy herds – silent spread in cattle demands integrated surveillance A farm-based investigation in the Netherlands screened milk and serum from 72 lactating cows and 38 youngstock...
Over the last week (≈23–29 June 2026), only a few jurisdictions and agencies released materially new vaccine guidance, with meaningful activity centered on COVID‑19 adult booster policy (Canada, Australia, New Zealand)...
Your one-stop source on tick-borne encephalitis With the 9th edition of our TBE Book, we are, once again, bringing together what has become the key reference on tick-borne encephalitis across EurAsia. Over the years...
The 2026 Bundibugyo ebolavirus outbreak in eastern DR Congo and Uganda has triggered an unprecedented acceleration of vaccine development for a strain that, until now, had no candidates even in Phase 1 trials. As of 22...
ASIA & OCEANIA India — Pulse Polio Immunization Day announced for 28 June 2026. The Ministry of Health & Family Welfare has mobilized for a nationwide Pulse Polio (National Immunization Day) on 28 June...
=1. Mpox joins the mRNA club: BioNTech’s first in-human BNT166a data hint at broad orthopox potential—but neutralizing titers fade fast In this phase 1, first-in-human, open-label dose escalation study, healthy Vaccinia...
Over roughly the last week (≈8–15 June 2026), the most concrete vaccine developments have been: (1) further consolidation of adult pneumococcal and RSV strategies in Australia, (2) new Canadian COVID-19 guidance for...
Extreme case report: more than 200 vaccine doses in 29 months A 62-year-old man from Magdeburg, Germany, received 217 COVID-19 vaccine doses over 29 months, with at least 134 doses documented in official records[1,3]...
For decades, the United States was the archetypal “vaccine nation” – a country that combined scientific innovation, regulatory strength, and broad uptake to drive vaccine‑preventable diseases to historic lows. Measles...
1. RSV-B fights back: French surveillance flags notable nirsevimab escape, stressing need for smarter long-term RSV strategies This multicenter prospective cohort (POLYRES) from 32 French hospitals (Sept 2024–Apr 2025)...